Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1374)
  2. Journal Article (1150)
  3. Review (130)
  4. Editorial (65)
  5. Research Letter (36)
  6. Book Section (25)
  7. Correspondence (24)
  8. Guidelines (12)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Hematology-Oncology Fellows (2746)
  2. Department of Medicine (2703)
  3. Solid Tumor Oncology Division (2002)
  4. Hematologic Malignancies, Division of (1330)
  5. GSK Faculty (1228)
  6. Department of Pathology and Laboratory Medicine (982)

More Groups

People
  1. Michael Berger (218)
  2. Marc Ladanyi (198)
  3. Pedram Razavi (184)
  4. Michael Offin (176)
  5. Sergio Giralt (171)
  6. Maria Carlo (168)

More People

Years
  1. 2025 (206)
  2. 2024 (414)
  3. 2023 (330)
  4. 2022 (377)
  5. 2021 (339)
  6. 2020 (323)

More Years

Publications
  1. Journal of Clinical Oncology (568)
  2. Blood (299)
  3. Annals of Oncology (107)
  4. Clinical Cancer Research (102)
  5. Journal of Thoracic Oncology (96)
  6. Cancer Research (87)

More Publications

Publishers
  1. American Society of Clinical Oncology (643)
  2. Elsevier Inc. (343)
  3. American Society of Hematology (339)
  4. American Association for Cancer Research (239)
  5. Nature Publishing Group (201)
  6. Oxford University Press (157)

More Publishers

Results (2819)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncogenic KRAS mediates resistance to MET targeted therapy in non-small cell lung cancer (NSCLC) with MET mutations that induce exon14 skipping
    Meeting Abstract

    Suzawa, K.; Offin, M. D.; Kurzatkowski, C.; Liu, D.; Vojnic, M.; Smith, R. S.; Mattar, M.; Khodos, I.; de Stanchina, E.; Sabari, J. K.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • A multifactorial model of T-cell expansion and durable clinical benefit in response to a PD-L1 inhibitor
    Meeting Abstract

    Leiserson, M. D.; Syrgkanis, V.; Gilson, A. I.; Dudik, M.; Funt, S. A.; Snyder, A.; Mackey, L.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • A phase Ib study of miransertib (ARQ 092) in combination with anastrozole in patients with PIK3CA or AKT1-mutant ER+ endometrial or ovarian cancer
    Meeting Abstract

    Hyman, D.; Bonafede, M.; O'Cearbhaill, R.; Grisham, R.; Zamarin, D.; Tew, W.; Aghajanian, C.; Cadoo, K.; Friedman, C.; Savage, R. E.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Noninvasive profiling of molecular dynamics in patients receiving HER2 targeted therapies by cell-free DNA analysis
    Meeting Abstract

    Gedvilaite, E.; Stewart, C.; Yang, J.; Reichel, J.; Stephens, D.; Offin, M. D.; Jing, X.; Meng, F.; You, D.; Berger, M. F.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Development and optimization of a comprehensive high-sensitivity NGS cancer assay and bioinformatics pipeline for plasma cfDNA profiling
    Meeting Abstract

    Patel, J.; Hasan, M.; Meng, F.; Jing, X.; Perera, D.; Reichel, J.; Gedvilaite, E.; Yang, J.; Shady, M.; Raj, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Somatostatin receptor-based imaging and treatment of murine pancreatic neuroendocrine tumors induced by MEN1-loss
    Meeting Abstract

    Li, J. W.; Zhang, H.; Carlin, S. D.; Raj, N.; Klimstra, D. S.; Libutti, S. K.; Weber, W. A.; Reidy-Lagunes, D.; Untch, B. R.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Functional and therapeutic significance of ESR1 gene fusions in breast cancer
    Meeting Abstract

    Lei, J. T.; Shao, J.; Zhang, J.; Iglesia, M.; Chan, D. W.; Cao, J.; Anurag, M.; Singh, P.; He, X.; Kosaka, Y.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Defined factors overcome T-cell exhaustion via abscopal effect
    Meeting Abstract

    Khalil, D.; Campesato, L. F.; Budhu, S.; Li, Y.; Jones, C.; Suek, N.; Liu, C.; Gasmi, B.; Giese, R.; Pourpe, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • A new twist to an old tale: Immunotherapy in non-muscle-invasive bladder cancer
    Journal Article

    Funt, S. A.; Pietzak, E. J.; Bajorin, D. F.
    European Urology Oncology (2018)

    Fulltext@MSK | Save
  • Survival outcomes and end of life use of immunotherapy (IO) supplied free of charge for cancer patients
    Meeting Abstract

    Agarwal, R.; Epstein, A. S.; Saltz, L. B.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save